Treating to target matrix metalloproteinase 3 normalisation together with disease activity score below 2.6 yields better effects than each alone in rheumatoid arthritis patients: T-4 Study

Yukitomo Urata, Ryoko Uesato, Dai Tanaka, Yoshihide Nakamura, Shigeru Motomura

Annals of the Rheumatic Diseases · 2011 · 42 citations · 21 references

Concepts

References

21